Cargando…
GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings
INTRODUCTION: The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569183/ https://www.ncbi.nlm.nih.gov/pubmed/26366871 http://dx.doi.org/10.1371/journal.pone.0137471 |
_version_ | 1782390001775935488 |
---|---|
author | Tadesse, Mulualem Abebe, Gemeda Abdissa, Ketema Aragaw, Dossegnaw Abdella, Kedir Bekele, Alemayehu Bezabih, Mesele Apers, Ludwig de Jong, Bouke C. Rigouts, Leen |
author_facet | Tadesse, Mulualem Abebe, Gemeda Abdissa, Ketema Aragaw, Dossegnaw Abdella, Kedir Bekele, Alemayehu Bezabih, Mesele Apers, Ludwig de Jong, Bouke C. Rigouts, Leen |
author_sort | Tadesse, Mulualem |
collection | PubMed |
description | INTRODUCTION: The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tuberculosis (EPTB). However, this was a conditional recommendation due to very low-quality evidence available and more studies are needed. In this study we evaluated the performance of Xpert for the diagnosis of TBL on concentrated fine needle aspirates (FNA) in Southwest Ethiopia. METHODS: FNA was collected from presumptive TBL cases. Two smears were prepared from each aspirate and processed for cytology and conventional microscopy. The remaining aspirate was treated with N-acetyl-L-cysteine-NaOH and centrifuged for 15minutes at 3000g. The concentrated sediment was used for culture and Xpert test. Capilia TB-Neo test was used to differentiate M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM). Composite bacteriological methods (culture and/or smear microscopy) were considered as a reference standard. RESULT: Out of 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard (CRS). Xpert detected M. tuberculosis complex (MTBC) in 60.1% (86/143) of the presumptive TBL cases. The sensitivity of Xpert compared to CRS was 87.8% [95% CI: 81.0–94.5] and specificity 91.1% [95% CI: 82.8–99.4]. The sensitivity was 27.8% for smear microscopy and 80% for cytology compared to CRS. Cytology showed the lowest specificity (57.8%). Xpert was positive in 4 out of 45 culture- and smear-negative cases. Among 47 cytomorphologically non-TBL cases, 15 were positive on Xpert. More than half of Xpert-positive cases were in the range of very low cut-off threshold values (28<Ct<38). Resistance to rifampicin was identified in 4.7% (4/86) of Xpert-positive cases. CONCLUSION: Xpert test showed a high sensitivity and specificity for the diagnosis of TBL on concentrated FNA samples. In addition, Xpert offered rapid detection of rifampicin-resistant M. tuberculosis strains from lymph node aspirates. |
format | Online Article Text |
id | pubmed-4569183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45691832015-09-18 GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings Tadesse, Mulualem Abebe, Gemeda Abdissa, Ketema Aragaw, Dossegnaw Abdella, Kedir Bekele, Alemayehu Bezabih, Mesele Apers, Ludwig de Jong, Bouke C. Rigouts, Leen PLoS One Research Article INTRODUCTION: The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tuberculosis (EPTB). However, this was a conditional recommendation due to very low-quality evidence available and more studies are needed. In this study we evaluated the performance of Xpert for the diagnosis of TBL on concentrated fine needle aspirates (FNA) in Southwest Ethiopia. METHODS: FNA was collected from presumptive TBL cases. Two smears were prepared from each aspirate and processed for cytology and conventional microscopy. The remaining aspirate was treated with N-acetyl-L-cysteine-NaOH and centrifuged for 15minutes at 3000g. The concentrated sediment was used for culture and Xpert test. Capilia TB-Neo test was used to differentiate M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM). Composite bacteriological methods (culture and/or smear microscopy) were considered as a reference standard. RESULT: Out of 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard (CRS). Xpert detected M. tuberculosis complex (MTBC) in 60.1% (86/143) of the presumptive TBL cases. The sensitivity of Xpert compared to CRS was 87.8% [95% CI: 81.0–94.5] and specificity 91.1% [95% CI: 82.8–99.4]. The sensitivity was 27.8% for smear microscopy and 80% for cytology compared to CRS. Cytology showed the lowest specificity (57.8%). Xpert was positive in 4 out of 45 culture- and smear-negative cases. Among 47 cytomorphologically non-TBL cases, 15 were positive on Xpert. More than half of Xpert-positive cases were in the range of very low cut-off threshold values (28<Ct<38). Resistance to rifampicin was identified in 4.7% (4/86) of Xpert-positive cases. CONCLUSION: Xpert test showed a high sensitivity and specificity for the diagnosis of TBL on concentrated FNA samples. In addition, Xpert offered rapid detection of rifampicin-resistant M. tuberculosis strains from lymph node aspirates. Public Library of Science 2015-09-14 /pmc/articles/PMC4569183/ /pubmed/26366871 http://dx.doi.org/10.1371/journal.pone.0137471 Text en © 2015 Tadesse et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Tadesse, Mulualem Abebe, Gemeda Abdissa, Ketema Aragaw, Dossegnaw Abdella, Kedir Bekele, Alemayehu Bezabih, Mesele Apers, Ludwig de Jong, Bouke C. Rigouts, Leen GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings |
title | GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings |
title_full | GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings |
title_fullStr | GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings |
title_full_unstemmed | GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings |
title_short | GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings |
title_sort | genexpert mtb/rif assay for the diagnosis of tuberculous lymphadenitis on concentrated fine needle aspirates in high tuberculosis burden settings |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569183/ https://www.ncbi.nlm.nih.gov/pubmed/26366871 http://dx.doi.org/10.1371/journal.pone.0137471 |
work_keys_str_mv | AT tadessemulualem genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT abebegemeda genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT abdissaketema genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT aragawdossegnaw genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT abdellakedir genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT bekelealemayehu genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT bezabihmesele genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT apersludwig genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT dejongboukec genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings AT rigoutsleen genexpertmtbrifassayforthediagnosisoftuberculouslymphadenitisonconcentratedfineneedleaspiratesinhightuberculosisburdensettings |